Radiopharm Theranostics Limited (ADR) (RADX) Live Share Price, Invest From India

Radiopharm Theranostics Limited (ADR) Stock Performance

as on August 6, 2026 at 6:59 am IST

Day's Low
Day's High
$2.70
Day's Price Range
$3.10
$2.73
1.10%
Downside
13.55%
Upside
52 Week's High
$2.73
52-Week Price Range
$16.25
$2.73
495.24%
Upside

Radiopharm Theranostics Limited (ADR) share price movements today

Previous Close: $2.92
Open: $2.88
Volume: 406.9K
Day's Low - High: $2.70 - $3.10
52 Week Low - High: $2.73 - $16.25

Radiopharm Theranostics Limited (ADR) Historical Returns

1 Month Return: -32.87 %
3 Month Return: -31.29 %
1 Year Return: -42.16 %
3 Year Return: 0 %
5 Year Return: 0 %

Radiopharm Theranostics Limited (ADR) Stock Fundamentals & Key Indicators

Check Radiopharm Theranostics Limited (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$24.5M

EPS (TTM)

-3.98

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-92.10%

Radiopharm Theranostics Limited (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Radiopharm Theranostics Limited (ADR) with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Radiopharm Theranostics Limited (ADR)	NA	$24.5M	NA	NA	-286.16%	NA
Revolution Medicines Inc.	BUY	$38.8B	591.42%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$119.5B	138.55%	27.95	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$78.2B	24.52%	18.78	27.87%	0.48%

Stock Returns calculator for Radiopharm Theranostics Limited (ADR) Stock including INR - Dollar returns

The Radiopharm Theranostics Limited (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Radiopharm Theranostics Limited (ADR) investment value today

Current value as on today

₹58,547

Returns

-₹41,453

(-41.45%)

Returns from Radiopharm Theranostics Limited (ADR) Stock

-₹45,941 (-45.94%)

Dollar Impact

₹4,487 (+4.49%)

Indian Investors' Interest in Radiopharm Theranostics Limited (ADR) Stock

Search interest for Radiopharm Theranostics Limited (ADR) Stock has increased by 352% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 7, 2026 to August 6, 2026

Change:352% versus previous 30 day period

Radiopharm Theranostics Limited (ADR) Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2025
Total Revenue	1
Gross Profit	-1
Operating Income	-30
EBITDA	-29
Interest Expense	0
Depreciation	-
Income Before Tax	-32
Income Tax Expense	-4
Net Income	-26
Net Profit Margin	-1946.20%

Radiopharm Theranostics Limited (ADR) Annual Profit & Loss

All numbers in Millions USD

	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	0	0	0	3
Gross Profit	0	0	0	0
Operating Income	-19	-34	-36	-38
EBITDA	-17	-31	-44	-38
Interest Expense	9	0	0	0
Depreciation	2	3	3	0
Income Before Tax	-30	-34	-47	-38
Income Tax Expense	0	0	0	0
Net Income	-21	-23	-31	-38
Net Profit Margin	-343550.89%	-11838.59%	-16024.28%	-1055.27%

Radiopharm Theranostics Limited (ADR) Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Dec 2025
Net Income	-	-	-	-	-26
Operating Cash Flow	-4	-7	-13	-8	-22
Investing Cash Flow	-	-	2	0	-5
Financing Cash Flow	5	22	38	-2	32
Change in Cash	1	15	27	-9	5

Radiopharm Theranostics Limited (ADR) Annual Cash Flow

All numbers in Millions USD

	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-30	-34	-47	-38
Operating Cash Flow	-9	-23	-22	-36
Investing Cash Flow	-28	-1	0	1
Financing Cash Flow	65	9	30	45
Change in Cash	26	-15	6	10

Global Institutional Holdings in Radiopharm Theranostics Limited (ADR)

Funds	Holdings
PNC Financial Services Group Inc	0.2%
UBS Group AG	0.04%
Strategic Wealth Partners	0%
Virtu Financial LLC	0%
Marex Group PLC	0%

See all

Insights on Radiopharm Theranostics Limited (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 403.9% return, outperforming this stock by 448.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, RADX stock has moved down by -7.3%

About Radiopharm Theranostics Limited (ADR)

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia.

Organisation	Radiopharm Theranostics Limited (ADR)
Headquarters	62 Lygon Street, Carlton, VIC, Australia, 3053
Industry	Biotechnology
CEO	Mr. Riccardo Canevari
E-voting on shares	Click here to vote

Key Management of Radiopharm Theranostics Limited (ADR)

Name	Title
Mr. Riccardo Canevari	MD, CEO & Director
Dr. Dimitris Voliotis M.D.	Chief Medical Officer
Mr. Aaron Laurita	Chief Financial Officer
Mr. Hitesh Goel	Head of Project Management
Mr. Nathan Jong C.A.	Joint Company Secretary
Ms. Amritha Sushil	Joint Company Secretary
Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD	Founder & Executive Chairman

FAQs

What is Radiopharm Theranostics Limited (ADR) share price today?

Radiopharm Theranostics Limited (ADR) share price today is $2.73 as on August 6, 2026 at 1:29 am IST at the close of the market. Radiopharm Theranostics Limited (ADR) share today touched a day high of $3.10 and a low of $2.70.

What is the 52 week high and 52 week low for Radiopharm Theranostics Limited (ADR) share?

Radiopharm Theranostics Limited (ADR) share touched a 52 week high of $16.25 on January 1, 1970 and a 52 week low of $2.73 on January 1, 1970. Radiopharm Theranostics Limited (ADR) stock price today i.e. August 6, 2026 at 1:29 am IST is closed at $2.73,which is 83.20% down from its 52 week high and 0.00% up from its 52 week low.

What is Radiopharm Theranostics Limited (ADR)'s market capitalisation today?

Radiopharm Theranostics Limited (ADR) market capitalisation is $0.00T as on August 6, 2026 at 1:29 am IST.

How to invest in Radiopharm Theranostics Limited (ADR) Stock (RADX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Radiopharm Theranostics Limited (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Radiopharm Theranostics Limited (ADR) Shares that will get you 0.5495 shares as per Radiopharm Theranostics Limited (ADR) share price of $2.73 per share as on August 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Radiopharm Theranostics Limited (ADR) Stock (RADX) from India?

Indian investors can start investing in Radiopharm Theranostics Limited (ADR) (RADX) shares with as little as ₹95.12 or $1 (as of August 6, 2026 at 3:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹951.20 in Radiopharm Theranostics Limited (ADR) stock (as per the Rupee-Dollar exchange rate as on August 6, 2026 at 3:43 am IST). Based on Radiopharm Theranostics Limited (ADR) share’s latest price of $2.73 as on August 6, 2026 at 1:29 am IST, you will get 3.6630 shares of Radiopharm Theranostics Limited (ADR). Learn more about fractional shares .